申请人:Janssen Pharmaceutica N.V.
公开号:US04471117A1
公开(公告)日:1984-09-11
This invention relates to 3,4-dihydro-2H-pyrimido[2,1-b]benzothiazoles displaying monoamine-oxidase inhibiting activity. The compounds are useful as antidepressants and anti-Parkinson agents.
这项发明涉及显示单胺氧化酶抑制活性的3,4-二氢-2H-嘧啶并[2,1-b]苯并噻唑化合物。这些化合物可用作抗抑郁药和抗帕金森病药物。